ONTX Past Earnings image   This ONTX past earnings page last updated 5/23/2022
ONTX Past Earnings
PeriodPast Earnings DateGAAP
Q1 20225/11/2022-0.200
Q4 20213/17/2022-0.160
Q3 202111/11/2021-0.220
Q2 20218/12/2021-0.270
Q1 20215/17/2021-0.300
Q4 20203/11/2021-0.450
Q3 202011/12/2020-0.450
Q2 20208/12/2020-0.600
Q1 20205/14/2020-0.450
Q4 20193/24/2020-5.850
Q3 201911/12/2019-11.250
Q2 20198/14/2019-9.000
Q1 20195/14/2019-19.350
Q4 20183/26/2019-12.750
Q3 201811/13/2018-14.100
Q2 20188/14/2018-15.750
Q1 20185/15/2018-76.500
Q4 20173/8/2018-132.750
Q3 201711/9/2017-159.750
Q2 20178/14/2017-65.250
Q1 20175/15/2017-276.750
Q4 20163/27/2017-121.500
Q3 201611/14/2016-65.250
Q2 20168/15/2016-441.000
Q1 20165/11/2016-607.500
Q4 20153/28/2016405.000
Q3 201511/11/2015-585.000
Q2 20158/13/2015-922.500
Q1 20155/14/2015-1282.500
Q4 20143/26/2015-1395.000
Q3 201411/13/2014-1552.500
Q2 20148/13/2014-1732.500
Q1 20145/12/2014-1957.500
Q4 20133/10/2014-1530.000
Q3 201311/14/2013-4410.000
Q2 20139/5/2013-11722.500
ONTX Past Revenue
PeriodPast Earnings DateGAAP
Q1 20225/11/20220.06M
Q4 20213/17/20220.06M
Q3 202111/11/20210.06M
Q2 20218/12/20210.06M
Q1 20215/17/20210.06M
Q4 20203/11/20210.06M
Q3 202011/12/20200.07M
Q2 20208/12/20200.06M
Q1 20205/14/20200.05M
Q4 20193/24/20200.03M
Q3 201911/12/20190.06M
Q2 20198/14/20190.00B
Q1 20195/14/20190.07M
Q4 20183/26/201959000
Q3 201811/13/2018120000
Q2 20188/14/2018485000
Q1 20185/15/2018564000
Q4 20173/8/2018143000
Q3 201711/9/2017110000
Q2 20178/14/2017324000
Q1 20175/15/2017210000
Q4 20163/27/2017173000
Q3 201611/14/20161.65M
Q2 20168/15/20162.25M
Q1 20165/11/20161.47M
Q4 20153/28/20169.60M
Q3 201511/11/20151.62M
Q2 20158/13/2015123000
Q1 20155/14/2015114000
Q4 20143/26/2015114000
Q3 201411/13/2014114000
Q2 20148/13/2014100000
Q1 20145/12/2014450000
Q4 20133/10/20141.93M
Q3 201311/14/20131.12M
Q2 20139/5/2013591000
Quotes delayed 20 minutes

Email EnvelopeFree ONTX Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Onconova Therapeutics (ONTX) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

ONVO Historical Earnings
OPCH Historical Earnings
OPGN Historical Earnings
OPK Historical Earnings
OPNT Historical Earnings
OPTN Historical Earnings
ORGO Historical Earnings
ORGS Historical Earnings
ORIC Historical Earnings
ORMP Historical Earnings

ONTX Past Earnings Q&A

What was the best and worst ONTX past earnings results?
For Onconova Therapeutics, I'm wondering what the company's very best and worst earnings results have been, on an earnings per share basis?

✔️Accepted answer: The highest ONTX past earnings result in our data set was 405.000/share posted in Q4 2015, while the lowest was in Q2 2013 when ONTX posted -11722.500/share.

  Suggested answer: The biggest top line earnings performance — aka revenue — quarter was in Q4 2015 when ONTX reported 9.60M in revenue, while the quarter with the lowest revenue in our data set was Q4 2019 at 0.03M of revenue.

  Suggested answer: There are 36 ONTX past earnings results in our data set.

On this page we presented the ONTX past earnings date information for Onconova Therapeutics. Reviewing that ONTX Past Earnings for the company, we see that the highest past earnings result in our data set was in Q4 2015, when ONTX posted gaap of 405.000/share. Meanwhile the lowest ONTX past earnings result was in Q2 2013, when ONTX posted gaap of -11722.500/share. Turning to top line revenue performance, the biggest revenue quarter in our data set was seen in Q4 2015 when ONTX reported 9.60M in revenue, while the smallest revenue quarter was Q4 2019 when ONTX reported 0.03M in revenue.

Any self directed investor doing their due diligence on ONTX or any other given stock can benefit from researching all of the Onconova Therapeutics past earnings — and here, we present each quarter's result all together on one page for easy comparison. Studying this information can help when projecting future earnings, as well as determining whether the past earnings trajectory justifies the current stock value. That's why we bring you PastEarnings.com to make it easy for investors to investigate Onconova Therapeutics past earnings, or the past earnings information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for ONTX. Thanks for visiting, and the next time you need to research ONTX past earnings or those of another stock, we hope you'll think of our site, as your go-to past earnings research resource of choice.

Recommended: SRNE Average Annual Return, CBFV Price Target, RSTI Videos.

 

ONTX Past Earnings | www.PastEarnings.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in PastEarnings.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.